An Open-label, Randomized, Fasted, Single-dose, Three-way Crossover Study to Compare the Pharmacokinetic Characteristics and Safety Between Administration of CKD-828 and Administration of D064,D701 in Healthy Adults
Latest Information Update: 16 Jan 2023
At a glance
- Drugs Levamlodipine/telmisartan (Primary) ; D-064/D-701
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
Most Recent Events
- 16 Jan 2023 Last checked against ClinicalTrials.gov record.
- 08 Jan 2023 Status changed from not yet recruiting to completed.
- 16 Sep 2022 New trial record